Anti-cancer activity

Anti-cancer activity is a descriptive term for the pharmacological effect of a drug or compound that inhibits the growth, proliferation, or spread of malignant cells (National Cancer Institute, 2023). It does not represent a single biological target, such as a protein or nucleic acid, but rather a functional outcome resulting from the modulation of various pathways, including DNA repair, signal transduction, or immune surveillance (NIH, 2022). In the context of drug discovery, this activity is evaluated through phenotypic screening in cell lines or animal models to determine the efficacy of antineoplastic agents (Nature Reviews Drug Discovery, 2018). Because this term encompasses a broad range of biological processes, it is considered a property of a therapeutic agent rather than a specific molecular receptor or enzyme intended for drug binding. For biotech analysts, distinguishing between a molecular target (e.g., HER2, KRAS) and a phenotypic outcome like anti-cancer activity is essential for accurate target validation and clinical development strategy.

Other names

Antineoplastic activityAntitumor activityCytotoxic activityAntiproliferative activity

Not applicable; 'Anti-cancer activity' refers to a therapeutic effect or physiological outcome rather than a specific molecular target like a receptor or enzyme.